PRYOR, Okla., July 11, 2018 /PRNewswire/ — On July 5, 2018, Xcaliber International, Ltd., L.L.C. (“Xcaliber”), a Pryor, Oklahoma based cigarette manufacturer, received 15 additional orders from the U.S. Food and Drug Administration, Center for Tobacco Products (“FDA”) finding certain tobacco products that it manufactures to be “substantially equivalent” within the meaning of the 2009 Family Smoking Prevention and Tobacco Control Act.

Xcaliber International

“Including these 15 SE orders, Xcaliber has received a total of 36 orders from the FDA finding its products to be substantially equivalent to those on the market in February 2007,” stated Derrick Taylor, Xcaliber’s Chief Executive Officer. “Pending the development and publication of new regulations by the FDA, all other products manufactured by the company have been removed from scientific review.”

“It is a good day for Xcaliber,” said Eric Estes, the company’s General Counsel. “We are extremely grateful to our staff, as well as our consultants and attorneys, for their work on this project. Their hard work and determination has paid off,” Estes continued.

Xcaliber is the largest, exclusively-focused Fourth Tier deep discount manufacturer in the United States. Xcaliber is built on a foundation of providing the highest value products in the Tier Four category.

For more information, please contact


Cision View original content with multimedia:

SOURCE Xcaliber International